Military Armament Corporation (MAC) is expanding its lineup in this market with the new-for-2025 MAC 9 Double-Stack (DS) Duty, DS Duty Comp and DS Comp pistols. The MAC 9 DS Duty adds a 5 ...

Among the new drugs to be launched is NIOPEG®, a biosimilar of NEULASTA®. Like NEULASTA®, NIOPEG® is a long-acting form of recombinant human granulocyte colony-stimulating factor (filgrastim).

Napp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following approval late last year. This is Napp’s first launch of a product developed ...

The title is a remake of the 2008 Nintendo DS game Harvest Moon: Grand Bazaar. The Story of Seasons remake launches for Nintendo Switch on August 27, 2025. Previous Story of Season remakes ...

As a remake, this is now a fully 3D version of the game. Players will head to Zephyr Town. There, they will not only farm and raise animals. They will also be tasked with running a booth at the ...

Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an asset purchase agreement signed by the companies in December 2024 for up ...

Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic. Neulasta brought in $4.5 billion ...

The corps is a holistic structure. And let’s not even talk about the ‘attached’ units that break brigades into battalions and, let’s be honest, are not valued as much as the ‘main’ ones. It is time to ...

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference ...